Shopping Cart 0
Cart Subtotal
USD 0

Global Oral Proteins and Peptides Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3480

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5220

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.

Scope of the Report:

This report focuses on the Oral Proteins and Peptides in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.

The U.S. is anticipated to generate the highest revenue in the oral proteins and peptides market in 2023. The rest of the world possesses high market potential for the growth of the market, owing to increase in awareness about oral peptide and protein therapeutics based treatment and rise in oral peptide and protein therapeutics applications. This region is anticipated to experience fast-paced growth, in terms of development and use of protein therapeutics.

The diabetes application is anticipated to occupy the largest share in the oral proteins and peptides market in 2023 owing to the high adoption of oral insulin, surge in geriatric population, and rise in prevalence of diabetes.

The worldwide market for Oral Proteins and Peptides is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Allergan

AstraZeneca

Biocon

Generex Biotechnology

Novo Nordisk

Synergy Pharmaceuticals

Tarsa Therapeutics

Sanofi

Hoffmann-La Roche

Synthetic Biologics

Hovione

Novartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Linaclotide

Plecanatide

Calcitonin

Insulin

Octreotide

Market Segment by Applications, can be divided into

Gastric & Digestive Disorders

Bone Diseases

Diabetes

Hormonal Disorders

There are 15 Chapters to deeply display the global Oral Proteins and Peptides market.

Chapter 1, to describe Oral Proteins and Peptides Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Oral Proteins and Peptides, with sales, revenue, and price of Oral Proteins and Peptides, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Oral Proteins and Peptides, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Oral Proteins and Peptides market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Oral Proteins and Peptides sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Oral Proteins and Peptides Introduction

1.2 Market Analysis by Type

1.2.1 Linaclotide

1.2.2 Plecanatide

1.2.3 Calcitonin

1.2.4 Insulin

1.2.5 Octreotide

1.3 Market Analysis by Applications

1.3.1 Gastric & Digestive Disorders

1.3.2 Bone Diseases

1.3.3 Diabetes

1.3.4 Hormonal Disorders

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Allergan

2.1.1 Business Overview

2.1.2 Oral Proteins and Peptides Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Allergan Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca

2.2.1 Business Overview

2.2.2 Oral Proteins and Peptides Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Biocon

2.3.1 Business Overview

2.3.2 Oral Proteins and Peptides Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biocon Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Generex Biotechnology

2.4.1 Business Overview

2.4.2 Oral Proteins and Peptides Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Generex Biotechnology Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novo Nordisk

2.5.1 Business Overview

2.5.2 Oral Proteins and Peptides Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novo Nordisk Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Synergy Pharmaceuticals

2.6.1 Business Overview

2.6.2 Oral Proteins and Peptides Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Tarsa Therapeutics

2.7.1 Business Overview

2.7.2 Oral Proteins and Peptides Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Tarsa Therapeutics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Sanofi

2.8.1 Business Overview

2.8.2 Oral Proteins and Peptides Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Sanofi Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Hoffmann-La Roche

2.9.1 Business Overview

2.9.2 Oral Proteins and Peptides Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Hoffmann-La Roche Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Synthetic Biologics

2.10.1 Business Overview

2.10.2 Oral Proteins and Peptides Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Synthetic Biologics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Hovione

2.11.1 Business Overview

2.11.2 Oral Proteins and Peptides Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Hovione Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Novartis

2.12.1 Business Overview

2.12.2 Oral Proteins and Peptides Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Novartis Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Oral Proteins and Peptides Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Oral Proteins and Peptides Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Oral Proteins and Peptides Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Oral Proteins and Peptides Manufacturer Market Share in 2017

3.3.2 Top 6 Oral Proteins and Peptides Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Oral Proteins and Peptides Market Analysis by Regions

4.1 Global Oral Proteins and Peptides Sales, Revenue and Market Share by Regions

4.1.1 Global Oral Proteins and Peptides Sales and Market Share by Regions (2013-2018)

4.1.2 Global Oral Proteins and Peptides Revenue and Market Share by Regions (2013-2018)

4.2 North America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

4.3 Europe Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

4.5 South America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

5 North America Oral Proteins and Peptides by Countries

5.1 North America Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

5.1.1 North America Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

5.1.2 North America Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

5.2 United States Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

5.3 Canada Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

5.4 Mexico Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6 Europe Oral Proteins and Peptides by Countries

6.1 Europe Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

6.1.1 Europe Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

6.2 Germany Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6.3 UK Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6.4 France Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6.5 Russia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6.6 Italy Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7 Asia-Pacific Oral Proteins and Peptides by Countries

7.1 Asia-Pacific Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

7.2 China Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7.3 Japan Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7.4 Korea Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7.5 India Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

8 South America Oral Proteins and Peptides by Countries

8.1 South America Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

8.1.1 South America Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

8.1.2 South America Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

8.3 Argentina Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

8.4 Colombia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9 Middle East and Africa Oral Proteins and Peptides by Countries

9.1 Middle East and Africa Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9.3 UAE Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9.4 Egypt Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9.5 Nigeria Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9.6 South Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

10 Global Oral Proteins and Peptides Market Segment by Type

10.1 Global Oral Proteins and Peptides Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Oral Proteins and Peptides Sales and Market Share by Type (2013-2018)

10.1.2 Global Oral Proteins and Peptides Revenue and Market Share by Type (2013-2018)

10.2 Linaclotide Sales Growth and Price

10.2.1 Global Linaclotide Sales Growth (2013-2018)

10.2.2 Global Linaclotide Price (2013-2018)

10.3 Plecanatide Sales Growth and Price

10.3.1 Global Plecanatide Sales Growth (2013-2018)

10.3.2 Global Plecanatide Price (2013-2018)

10.4 Calcitonin Sales Growth and Price

10.4.1 Global Calcitonin Sales Growth (2013-2018)

10.4.2 Global Calcitonin Price (2013-2018)

10.5 Insulin Sales Growth and Price

10.5.1 Global Insulin Sales Growth (2013-2018)

10.5.2 Global Insulin Price (2013-2018)

10.6 Octreotide Sales Growth and Price

10.6.1 Global Octreotide Sales Growth (2013-2018)

10.6.2 Global Octreotide Price (2013-2018)

11 Global Oral Proteins and Peptides Market Segment by Application

11.1 Global Oral Proteins and Peptides Sales Market Share by Application (2013-2018)

11.2 Gastric & Digestive Disorders Sales Growth (2013-2018)

11.3 Bone Diseases Sales Growth (2013-2018)

11.4 Diabetes Sales Growth (2013-2018)

11.5 Hormonal Disorders Sales Growth (2013-2018)

12 Oral Proteins and Peptides Market Forecast (2018-2023)

12.1 Global Oral Proteins and Peptides Sales, Revenue and Growth Rate (2018-2023)

12.2 Oral Proteins and Peptides Market Forecast by Regions (2018-2023)

12.2.1 North America Oral Proteins and Peptides Market Forecast (2018-2023)

12.2.2 Europe Oral Proteins and Peptides Market Forecast (2018-2023)

12.2.3 Asia-Pacific Oral Proteins and Peptides Market Forecast (2018-2023)

12.2.4 South America Oral Proteins and Peptides Market Forecast (2018-2023)

12.2.5 Middle East and Africa Oral Proteins and Peptides Market Forecast (2018-2023)

12.3 Oral Proteins and Peptides Market Forecast by Type (2018-2023)

12.3.1 Global Oral Proteins and Peptides Sales Forecast by Type (2018-2023)

12.3.2 Global Oral Proteins and Peptides Market Share Forecast by Type (2018-2023)

12.4 Oral Proteins and Peptides Market Forecast by Application (2018-2023)

12.4.1 Global Oral Proteins and Peptides Sales Forecast by Application (2018-2023)

12.4.2 Global Oral Proteins and Peptides Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Oral Proteins and Peptides Picture

Table Product Specifications of Oral Proteins and Peptides

Figure Global Sales Market Share of Oral Proteins and Peptides by Types in 2017

Table Oral Proteins and Peptides Types for Major Manufacturers

Figure Linaclotide Picture

Figure Plecanatide Picture

Figure Calcitonin Picture

Figure Insulin Picture

Figure Octreotide Picture

Figure Oral Proteins and Peptides Sales Market Share by Applications in 2017

Figure Gastric & Digestive Disorders Picture

Figure Bone Diseases Picture

Figure Diabetes Picture

Figure Hormonal Disorders Picture

Figure United States Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure France Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure UK Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure China Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure India Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Oral Proteins and Peptides Type and Applications

Table Allergan Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Oral Proteins and Peptides Type and Applications

Table AstraZeneca Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biocon Basic Information, Manufacturing Base and Competitors

Table Biocon Oral Proteins and Peptides Type and Applications

Table Biocon Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Generex Biotechnology Basic Information, Manufacturing Base and Competitors

Table Generex Biotechnology Oral Proteins and Peptides Type and Applications

Table Generex Biotechnology Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk Oral Proteins and Peptides Type and Applications

Table Novo Nordisk Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Synergy Pharmaceuticals Oral Proteins and Peptides Type and Applications

Table Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Tarsa Therapeutics Basic Information, Manufacturing Base and Competitors

Table Tarsa Therapeutics Oral Proteins and Peptides Type and Applications

Table Tarsa Therapeutics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Oral Proteins and Peptides Type and Applications

Table Sanofi Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors

Table Hoffmann-La Roche Oral Proteins and Peptides Type and Applications

Table Hoffmann-La Roche Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Synthetic Biologics Basic Information, Manufacturing Base and Competitors

Table Synthetic Biologics Oral Proteins and Peptides Type and Applications

Table Synthetic Biologics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hovione Basic Information, Manufacturing Base and Competitors

Table Hovione Oral Proteins and Peptides Type and Applications

Table Hovione Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Oral Proteins and Peptides Type and Applications

Table Novartis Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Oral Proteins and Peptides Sales by Manufacturer (2016-2017)

Figure Global Oral Proteins and Peptides Sales Market Share by Manufacturer in 2016

Figure Global Oral Proteins and Peptides Sales Market Share by Manufacturer in 2017

Table Global Oral Proteins and Peptides Revenue by Manufacturer (2016-2017)

Figure Global Oral Proteins and Peptides Revenue Market Share by Manufacturer in 2016

Figure Global Oral Proteins and Peptides Revenue Market Share by Manufacturer in 2017

Figure Top 3 Oral Proteins and Peptides Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Oral Proteins and Peptides Manufacturer (Revenue) Market Share in 2017

Figure Global Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Global Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table Global Oral Proteins and Peptides Sales by Regions (2013-2018)

Table Global Oral Proteins and Peptides Sales Market Share by Regions (2013-2018)

Table Global Oral Proteins and Peptides Revenue by Regions (2013-2018)

Figure Global Oral Proteins and Peptides Revenue Market Share by Regions in 2013

Figure Global Oral Proteins and Peptides Revenue Market Share by Regions in 2017

Figure North America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Europe Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure South America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure North America Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table North America Oral Proteins and Peptides Sales by Countries (2013-2018)

Table North America Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Figure North America Oral Proteins and Peptides Sales Market Share by Countries in 2013

Figure North America Oral Proteins and Peptides Sales Market Share by Countries in 2017

Table North America Oral Proteins and Peptides Revenue by Countries (2013-2018)

Table North America Oral Proteins and Peptides Revenue Market Share by Countries (2013-2018)

Figure North America Oral Proteins and Peptides Revenue Market Share by Countries in 2013

Figure North America Oral Proteins and Peptides Revenue Market Share by Countries in 2017

Figure United States Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Canada Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Mexico Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Europe Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table Europe Oral Proteins and Peptides Sales by Countries (2013-2018)

Table Europe Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Table Europe Oral Proteins and Peptides Revenue by Countries (2013-2018)

Figure Europe Oral Proteins and Peptides Revenue Market Share by Countries in 2016

Figure Europe Oral Proteins and Peptides Revenue Market Share by Countries in 2017

Figure Germany Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure UK Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure France Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Russia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Italy Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Oral Proteins and Peptides Sales by Countries (2013-2018)

Table Asia-Pacific Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Oral Proteins and Peptides Sales Market Share by Countries 2017

Table Asia-Pacific Oral Proteins and Peptides Revenue by Countries (2013-2018)

Figure Asia-Pacific Oral Proteins and Peptides Revenue Market Share by Countries 2017

Figure China Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Japan Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Korea Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure India Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Southeast Asia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure South America Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table South America Oral Proteins and Peptides Sales by Countries (2013-2018)

Table South America Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Figure South America Oral Proteins and Peptides Sales Market Share by Countries in 2017

Table South America Oral Proteins and Peptides Revenue by Countries (2013-2018)

Table South America Oral Proteins and Peptides Revenue Market Share by Countries (2013-2018)

Figure South America Oral Proteins and Peptides Revenue Market Share by Countries in 2017

Figure Brazil Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Argentina Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Colombia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Oral Proteins and Peptides Sales by Countries (2013-2018)

Table Middle East and Africa Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Oral Proteins and Peptides Sales Market Share by Countries in 2017

Table Middle East and Africa Oral Proteins and Peptides Revenue by Countries (2013-2018)

Table Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Countries in 2013

Figure Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Countries in 2017

Figure Saudi Arabia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure UAE Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Egypt Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Nigeria Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure South Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Table Global Oral Proteins and Peptides Sales by Type (2013-2018)

Table Global Oral Proteins and Peptides Sales Share by Type (2013-2018)

Table Global Oral Proteins and Peptides Revenue by Type (2013-2018)

Table Global Oral Proteins and Peptides Revenue Share by Type (2013-2018)

Figure Global Linaclotide Sales Growth (2013-2018)

Figure Global Linaclotide Price (2013-2018)

Figure Global Plecanatide Sales Growth (2013-2018)

Figure Global Plecanatide Price (2013-2018)

Figure Global Calcitonin Sales Growth (2013-2018)

Figure Global Calcitonin Price (2013-2018)

Figure Global Insulin Sales Growth (2013-2018)

Figure Global Insulin Price (2013-2018)

Figure Global Octreotide Sales Growth (2013-2018)

Figure Global Octreotide Price (2013-2018)

Table Global Oral Proteins and Peptides Sales by Application (2013-2018)

Table Global Oral Proteins and Peptides Sales Share by Application (2013-2018)

Figure Global Bone Diseases Sales Growth (2013-2018)

Figure Global Diabetes Sales Growth (2013-2018)

Figure Global Hormonal Disorders Sales Growth (2013-2018)

Figure Global Oral Proteins and Peptides Sales, Revenue and Growth Rate (2018-2023)

Table Global Oral Proteins and Peptides Sales Forecast by Regions (2018-2023)

Table Global Oral Proteins and Peptides Market Share Forecast by Regions (2018-2023)

Figure North America Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Figure Europe Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Figure Asia-Pacific Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Figure South America Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Figure Middle East and Africa Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Table Global Oral Proteins and Peptides Sales Forecast by Type (2018-2023)

Table Global Oral Proteins and Peptides Market Share Forecast by Type (2018-2023)

Table Global Oral Proteins and Peptides Sales Forecast by Application (2018-2023)

Table Global Oral Proteins and Peptides Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Allergan

AstraZeneca

Biocon

Generex Biotechnology

Novo Nordisk

Synergy Pharmaceuticals

Tarsa Therapeutics

Sanofi

Hoffmann-La Roche

Synthetic Biologics

Hovione

Novartis

Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.

Scope of the Report:

This report focuses on the Oral Proteins and Peptides in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.

The U.S. is anticipated to generate the highest revenue in the oral proteins and peptides market in 2023. The rest of the world possesses high market potential for the growth of the market, owing to increase in awareness about oral peptide and protein therapeutics based treatment and rise in oral peptide and protein therapeutics applications. This region is anticipated to experience fast-paced growth, in terms of development and use of protein therapeutics.

The diabetes application is anticipated to occupy the largest share in the oral proteins and peptides market in 2023 owing to the high adoption of oral insulin, surge in geriatric population, and rise in prevalence of diabetes.

The worldwide market for Oral Proteins and Peptides is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Allergan

AstraZeneca

Biocon

Generex Biotechnology

Novo Nordisk

Synergy Pharmaceuticals

Tarsa Therapeutics

Sanofi

Hoffmann-La Roche

Synthetic Biologics

Hovione

Novartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Linaclotide

Plecanatide

Calcitonin

Insulin

Octreotide

Market Segment by Applications, can be divided into

Gastric & Digestive Disorders

Bone Diseases

Diabetes

Hormonal Disorders

There are 15 Chapters to deeply display the global Oral Proteins and Peptides market.

Chapter 1, to describe Oral Proteins and Peptides Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Oral Proteins and Peptides, with sales, revenue, and price of Oral Proteins and Peptides, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Oral Proteins and Peptides, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Oral Proteins and Peptides market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Oral Proteins and Peptides sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Oral Proteins and Peptides Introduction

1.2 Market Analysis by Type

1.2.1 Linaclotide

1.2.2 Plecanatide

1.2.3 Calcitonin

1.2.4 Insulin

1.2.5 Octreotide

1.3 Market Analysis by Applications

1.3.1 Gastric & Digestive Disorders

1.3.2 Bone Diseases

1.3.3 Diabetes

1.3.4 Hormonal Disorders

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Allergan

2.1.1 Business Overview

2.1.2 Oral Proteins and Peptides Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Allergan Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca

2.2.1 Business Overview

2.2.2 Oral Proteins and Peptides Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Biocon

2.3.1 Business Overview

2.3.2 Oral Proteins and Peptides Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biocon Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Generex Biotechnology

2.4.1 Business Overview

2.4.2 Oral Proteins and Peptides Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Generex Biotechnology Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novo Nordisk

2.5.1 Business Overview

2.5.2 Oral Proteins and Peptides Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novo Nordisk Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Synergy Pharmaceuticals

2.6.1 Business Overview

2.6.2 Oral Proteins and Peptides Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Tarsa Therapeutics

2.7.1 Business Overview

2.7.2 Oral Proteins and Peptides Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Tarsa Therapeutics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Sanofi

2.8.1 Business Overview

2.8.2 Oral Proteins and Peptides Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Sanofi Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Hoffmann-La Roche

2.9.1 Business Overview

2.9.2 Oral Proteins and Peptides Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Hoffmann-La Roche Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Synthetic Biologics

2.10.1 Business Overview

2.10.2 Oral Proteins and Peptides Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Synthetic Biologics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Hovione

2.11.1 Business Overview

2.11.2 Oral Proteins and Peptides Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Hovione Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Novartis

2.12.1 Business Overview

2.12.2 Oral Proteins and Peptides Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Novartis Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Oral Proteins and Peptides Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Oral Proteins and Peptides Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Oral Proteins and Peptides Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Oral Proteins and Peptides Manufacturer Market Share in 2017

3.3.2 Top 6 Oral Proteins and Peptides Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Oral Proteins and Peptides Market Analysis by Regions

4.1 Global Oral Proteins and Peptides Sales, Revenue and Market Share by Regions

4.1.1 Global Oral Proteins and Peptides Sales and Market Share by Regions (2013-2018)

4.1.2 Global Oral Proteins and Peptides Revenue and Market Share by Regions (2013-2018)

4.2 North America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

4.3 Europe Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

4.5 South America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

5 North America Oral Proteins and Peptides by Countries

5.1 North America Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

5.1.1 North America Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

5.1.2 North America Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

5.2 United States Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

5.3 Canada Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

5.4 Mexico Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6 Europe Oral Proteins and Peptides by Countries

6.1 Europe Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

6.1.1 Europe Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

6.2 Germany Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6.3 UK Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6.4 France Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6.5 Russia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

6.6 Italy Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7 Asia-Pacific Oral Proteins and Peptides by Countries

7.1 Asia-Pacific Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

7.2 China Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7.3 Japan Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7.4 Korea Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7.5 India Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

8 South America Oral Proteins and Peptides by Countries

8.1 South America Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

8.1.1 South America Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

8.1.2 South America Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

8.3 Argentina Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

8.4 Colombia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9 Middle East and Africa Oral Proteins and Peptides by Countries

9.1 Middle East and Africa Oral Proteins and Peptides Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9.3 UAE Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9.4 Egypt Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9.5 Nigeria Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

9.6 South Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

10 Global Oral Proteins and Peptides Market Segment by Type

10.1 Global Oral Proteins and Peptides Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Oral Proteins and Peptides Sales and Market Share by Type (2013-2018)

10.1.2 Global Oral Proteins and Peptides Revenue and Market Share by Type (2013-2018)

10.2 Linaclotide Sales Growth and Price

10.2.1 Global Linaclotide Sales Growth (2013-2018)

10.2.2 Global Linaclotide Price (2013-2018)

10.3 Plecanatide Sales Growth and Price

10.3.1 Global Plecanatide Sales Growth (2013-2018)

10.3.2 Global Plecanatide Price (2013-2018)

10.4 Calcitonin Sales Growth and Price

10.4.1 Global Calcitonin Sales Growth (2013-2018)

10.4.2 Global Calcitonin Price (2013-2018)

10.5 Insulin Sales Growth and Price

10.5.1 Global Insulin Sales Growth (2013-2018)

10.5.2 Global Insulin Price (2013-2018)

10.6 Octreotide Sales Growth and Price

10.6.1 Global Octreotide Sales Growth (2013-2018)

10.6.2 Global Octreotide Price (2013-2018)

11 Global Oral Proteins and Peptides Market Segment by Application

11.1 Global Oral Proteins and Peptides Sales Market Share by Application (2013-2018)

11.2 Gastric & Digestive Disorders Sales Growth (2013-2018)

11.3 Bone Diseases Sales Growth (2013-2018)

11.4 Diabetes Sales Growth (2013-2018)

11.5 Hormonal Disorders Sales Growth (2013-2018)

12 Oral Proteins and Peptides Market Forecast (2018-2023)

12.1 Global Oral Proteins and Peptides Sales, Revenue and Growth Rate (2018-2023)

12.2 Oral Proteins and Peptides Market Forecast by Regions (2018-2023)

12.2.1 North America Oral Proteins and Peptides Market Forecast (2018-2023)

12.2.2 Europe Oral Proteins and Peptides Market Forecast (2018-2023)

12.2.3 Asia-Pacific Oral Proteins and Peptides Market Forecast (2018-2023)

12.2.4 South America Oral Proteins and Peptides Market Forecast (2018-2023)

12.2.5 Middle East and Africa Oral Proteins and Peptides Market Forecast (2018-2023)

12.3 Oral Proteins and Peptides Market Forecast by Type (2018-2023)

12.3.1 Global Oral Proteins and Peptides Sales Forecast by Type (2018-2023)

12.3.2 Global Oral Proteins and Peptides Market Share Forecast by Type (2018-2023)

12.4 Oral Proteins and Peptides Market Forecast by Application (2018-2023)

12.4.1 Global Oral Proteins and Peptides Sales Forecast by Application (2018-2023)

12.4.2 Global Oral Proteins and Peptides Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Oral Proteins and Peptides Picture

Table Product Specifications of Oral Proteins and Peptides

Figure Global Sales Market Share of Oral Proteins and Peptides by Types in 2017

Table Oral Proteins and Peptides Types for Major Manufacturers

Figure Linaclotide Picture

Figure Plecanatide Picture

Figure Calcitonin Picture

Figure Insulin Picture

Figure Octreotide Picture

Figure Oral Proteins and Peptides Sales Market Share by Applications in 2017

Figure Gastric & Digestive Disorders Picture

Figure Bone Diseases Picture

Figure Diabetes Picture

Figure Hormonal Disorders Picture

Figure United States Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure France Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure UK Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure China Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure India Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Oral Proteins and Peptides Revenue (Value) and Growth Rate (2013-2023)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Oral Proteins and Peptides Type and Applications

Table Allergan Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Oral Proteins and Peptides Type and Applications

Table AstraZeneca Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biocon Basic Information, Manufacturing Base and Competitors

Table Biocon Oral Proteins and Peptides Type and Applications

Table Biocon Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Generex Biotechnology Basic Information, Manufacturing Base and Competitors

Table Generex Biotechnology Oral Proteins and Peptides Type and Applications

Table Generex Biotechnology Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novo Nordisk Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk Oral Proteins and Peptides Type and Applications

Table Novo Nordisk Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Synergy Pharmaceuticals Oral Proteins and Peptides Type and Applications

Table Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Tarsa Therapeutics Basic Information, Manufacturing Base and Competitors

Table Tarsa Therapeutics Oral Proteins and Peptides Type and Applications

Table Tarsa Therapeutics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Oral Proteins and Peptides Type and Applications

Table Sanofi Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors

Table Hoffmann-La Roche Oral Proteins and Peptides Type and Applications

Table Hoffmann-La Roche Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Synthetic Biologics Basic Information, Manufacturing Base and Competitors

Table Synthetic Biologics Oral Proteins and Peptides Type and Applications

Table Synthetic Biologics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hovione Basic Information, Manufacturing Base and Competitors

Table Hovione Oral Proteins and Peptides Type and Applications

Table Hovione Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Oral Proteins and Peptides Type and Applications

Table Novartis Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Oral Proteins and Peptides Sales by Manufacturer (2016-2017)

Figure Global Oral Proteins and Peptides Sales Market Share by Manufacturer in 2016

Figure Global Oral Proteins and Peptides Sales Market Share by Manufacturer in 2017

Table Global Oral Proteins and Peptides Revenue by Manufacturer (2016-2017)

Figure Global Oral Proteins and Peptides Revenue Market Share by Manufacturer in 2016

Figure Global Oral Proteins and Peptides Revenue Market Share by Manufacturer in 2017

Figure Top 3 Oral Proteins and Peptides Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Oral Proteins and Peptides Manufacturer (Revenue) Market Share in 2017

Figure Global Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Global Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table Global Oral Proteins and Peptides Sales by Regions (2013-2018)

Table Global Oral Proteins and Peptides Sales Market Share by Regions (2013-2018)

Table Global Oral Proteins and Peptides Revenue by Regions (2013-2018)

Figure Global Oral Proteins and Peptides Revenue Market Share by Regions in 2013

Figure Global Oral Proteins and Peptides Revenue Market Share by Regions in 2017

Figure North America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Europe Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure South America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure North America Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table North America Oral Proteins and Peptides Sales by Countries (2013-2018)

Table North America Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Figure North America Oral Proteins and Peptides Sales Market Share by Countries in 2013

Figure North America Oral Proteins and Peptides Sales Market Share by Countries in 2017

Table North America Oral Proteins and Peptides Revenue by Countries (2013-2018)

Table North America Oral Proteins and Peptides Revenue Market Share by Countries (2013-2018)

Figure North America Oral Proteins and Peptides Revenue Market Share by Countries in 2013

Figure North America Oral Proteins and Peptides Revenue Market Share by Countries in 2017

Figure United States Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Canada Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Mexico Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Europe Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table Europe Oral Proteins and Peptides Sales by Countries (2013-2018)

Table Europe Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Table Europe Oral Proteins and Peptides Revenue by Countries (2013-2018)

Figure Europe Oral Proteins and Peptides Revenue Market Share by Countries in 2016

Figure Europe Oral Proteins and Peptides Revenue Market Share by Countries in 2017

Figure Germany Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure UK Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure France Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Russia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Italy Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Oral Proteins and Peptides Sales by Countries (2013-2018)

Table Asia-Pacific Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Oral Proteins and Peptides Sales Market Share by Countries 2017

Table Asia-Pacific Oral Proteins and Peptides Revenue by Countries (2013-2018)

Figure Asia-Pacific Oral Proteins and Peptides Revenue Market Share by Countries 2017

Figure China Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Japan Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Korea Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure India Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Southeast Asia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure South America Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table South America Oral Proteins and Peptides Sales by Countries (2013-2018)

Table South America Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Figure South America Oral Proteins and Peptides Sales Market Share by Countries in 2017

Table South America Oral Proteins and Peptides Revenue by Countries (2013-2018)

Table South America Oral Proteins and Peptides Revenue Market Share by Countries (2013-2018)

Figure South America Oral Proteins and Peptides Revenue Market Share by Countries in 2017

Figure Brazil Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Argentina Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Colombia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Oral Proteins and Peptides Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Oral Proteins and Peptides Sales by Countries (2013-2018)

Table Middle East and Africa Oral Proteins and Peptides Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Oral Proteins and Peptides Sales Market Share by Countries in 2017

Table Middle East and Africa Oral Proteins and Peptides Revenue by Countries (2013-2018)

Table Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Countries in 2013

Figure Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Countries in 2017

Figure Saudi Arabia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure UAE Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Egypt Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure Nigeria Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Figure South Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)

Table Global Oral Proteins and Peptides Sales by Type (2013-2018)

Table Global Oral Proteins and Peptides Sales Share by Type (2013-2018)

Table Global Oral Proteins and Peptides Revenue by Type (2013-2018)

Table Global Oral Proteins and Peptides Revenue Share by Type (2013-2018)

Figure Global Linaclotide Sales Growth (2013-2018)

Figure Global Linaclotide Price (2013-2018)

Figure Global Plecanatide Sales Growth (2013-2018)

Figure Global Plecanatide Price (2013-2018)

Figure Global Calcitonin Sales Growth (2013-2018)

Figure Global Calcitonin Price (2013-2018)

Figure Global Insulin Sales Growth (2013-2018)

Figure Global Insulin Price (2013-2018)

Figure Global Octreotide Sales Growth (2013-2018)

Figure Global Octreotide Price (2013-2018)

Table Global Oral Proteins and Peptides Sales by Application (2013-2018)

Table Global Oral Proteins and Peptides Sales Share by Application (2013-2018)

Figure Global Bone Diseases Sales Growth (2013-2018)

Figure Global Diabetes Sales Growth (2013-2018)

Figure Global Hormonal Disorders Sales Growth (2013-2018)

Figure Global Oral Proteins and Peptides Sales, Revenue and Growth Rate (2018-2023)

Table Global Oral Proteins and Peptides Sales Forecast by Regions (2018-2023)

Table Global Oral Proteins and Peptides Market Share Forecast by Regions (2018-2023)

Figure North America Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Figure Europe Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Figure Asia-Pacific Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Figure South America Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Figure Middle East and Africa Sales Oral Proteins and Peptides Market Forecast (2018-2023)

Table Global Oral Proteins and Peptides Sales Forecast by Type (2018-2023)

Table Global Oral Proteins and Peptides Market Share Forecast by Type (2018-2023)

Table Global Oral Proteins and Peptides Sales Forecast by Application (2018-2023)

Table Global Oral Proteins and Peptides Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Allergan

AstraZeneca

Biocon

Generex Biotechnology

Novo Nordisk

Synergy Pharmaceuticals

Tarsa Therapeutics

Sanofi

Hoffmann-La Roche

Synthetic Biologics

Hovione

Novartis